Turning Point Therapeutics’ CEO to Present at Goldman Sachs 40th Annual Global Healthcare Conference


You May Also Like

Abiomed Surpasses 50,000 Impella® Patients Treated in the United States

DANVERS, Mass., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Abiomed, Inc. (NASDAQ:ABMD), a leading provider ...

Vical to Host Virtual Research & Development Day on May 2, 2017

SAN DIEGO, April 24, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that ...